Cell Biotech Co. Ltd (049960.KQ) stock: key figures, P/E, revenue and dividend
Health Care · Biotechnology · South Korea · ISIN KR7049960008
Cell Biotech Co. Ltd financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 49.91 bn KRW | 53.13 bn KRW |
| Gross profit | 36.06 bn KRW | 38.62 bn KRW |
| Operating income | 6.80 bn KRW | 7.91 bn KRW |
| EBIT | 15.67 bn KRW | 11.29 bn KRW |
| Net income | 15.13 bn KRW | 10.13 bn KRW |
| Diluted EPS – continuing operations | 2,210.25 KRW | 1,479.45 KRW |
Full history since 2011, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Cell Biotech Co. Ltd
Cell Biotech Co., Ltd., a biotechnology company, develops and sells lactic acid bacteria in South Korea. It also offers probiotic products under the Nutra DUOLAC, LACTOClear, and LAB2PRO brands. The company also exports its products to approximately 40 countries, including the United States, Europe, Japan, and China. Cell Biotech Co., Ltd. was founded in 1995 and is based in Gimpo-si, South Korea.
More stocks
- Hwang-Kum Stee (032560.KS)
- Lexibook Linguistic Electronic System SA (ALLEX.PA)
- Ezwelfare Co Ltd (090850.KQ)
- Cameo Communications Inc (6142.TW)
- AurosTechnology Inc. (322310.KQ)
- Asarian Energy Limited (ARN.TO)
- Microbot Medical Inc. (MBOT)
- ACRES Commercial Realty Corp. (ACR)
- VivoPower PLC (VIVO)
- Groundhog Inc. (6906.TW)
- Bangkok Lab & Cosmetic PCL (BLC.BK)
- Marisa Lojas S.A (AMAR3.SA)
Not investment advice. All data without warranty, price as of 30.10.2026. Details in the risk notice.